Abstract
The goal of the German Mammography Screening Program (MSP) is to enable the early detection and less intensive treatment of breast cancer. We compared tumor characteristics and prognostic markers in breast cancers that were detected by screening in the MSP, in the interval after a negative screening, or among non-participants in screening. This retrospective series includes all of the 1531 cases of invasive and in situ breast cancer (DCIS, ductal carcinoma in situ) that were newly diagnosed in two certified breast care centers in Münster in the period 2006-2012 among women in the MSP target population. Complete information on the tumor characteristics, tumor biology, and primary surgical treatment were available for all cases. The mode of cancer detection was determined from the state cancer registry of North Rhine-Westphalia. Due to the retrospective design of this case series, there was no randomized allocation. The 874 cases of breast cancer among MSP participants (714 detected by screening, 160 in the interval after a negative screen) and the 657 cases among non-participants arose in women of similar age (mean, 60.2 versus 59.3 years). MSP participants with breast cancer had DCIS more commonly than non-participants did (23%...Continue Reading
References
May 4, 2000·Journal of the National Cancer Institute·F D GillilandC R Key
Jul 24, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·S E Hall, C D J Holman
Jul 31, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M J M BroedersR Holland
Sep 30, 2006·Journal of Medical Screening·Gareth J R PorterJ Chakrabarti
Feb 10, 2007·International Journal of Cancer. Journal International Du Cancer·Andrew J ColdmanCaroline Speers
Oct 28, 2009·RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin·S WeigelW Heindel
Mar 30, 2010·Cancer Causes & Control : CCC·Laia DomingoXavier Castells
Mar 23, 2011·Clinical Breast Cancer·Daniel RaysonJudy Caines
Dec 14, 2012·BMC Medicine·Philippe Autier, Mathieu Boniol
Dec 25, 2012·Deutsches Ärzteblatt International·Oliver HeidingerHans-Werner Hense
May 25, 2013·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·A Starker, A-C Saß
Jun 19, 2013·European Journal of Epidemiology·Andreas StangOliver Kuss
Dec 21, 2013·Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·A FuhsH-W Hense
Aug 3, 2014·BMC Cancer·Gemma Renart-VicensRafael Marcos-Gragera
Nov 5, 2014·Journal of the National Cancer Institute·Ruth EtzioniRoman Gulati
Nov 20, 2015·Journal of Medical Screening·Solveig HofvindLars Akslen
Apr 14, 2016·Nature Reviews. Clinical Oncology·Yiwey ShiehLaura J Esserman
Aug 6, 2016·Breast Care·Daniela Malek, Vanessa Kääb-Sanyal
Nov 21, 2016·Lancet·Nadia Harbeck, Michael Gnant
Jun 27, 2017·NPJ Breast Cancer·Nehmat Houssami, Kylie Hunter
Sep 8, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Merete Ellingjord-DaleGiske Ursin